• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Introduction to cis-2-tert-Butoxycarbonylamino-2-methyl-cyclopentanecarboxylic Acid (CAS No. 1212127-10-0)

cis-2-tert-Butoxycarbonylamino-2-methyl-cyclopentanecarboxylic Acid, identified by the CAS number 1212127-10-0, is a compound of significant interest in the fields of organic chemistry and pharmaceutical research. This compound is characterized by its unique structure, which includes a cyclopentane ring substituted with a tert-butoxycarbonylamino group and a methyl group in the cis configuration. The presence of these functional groups makes it a versatile molecule with potential applications in drug design and material science.

Recent studies have highlighted the importance of stereochemistry in determining the biological activity of compounds like cis-2-tert-Butoxycarbonylamino-2-methyl-cyclopentanecarboxylic Acid. Researchers have found that the cis configuration plays a critical role in molecular recognition and binding affinity, making it a promising candidate for developing enantioselective drugs. The tert-butoxycarbonyl (Boc) group, a common protecting group in peptide synthesis, adds another layer of functionality, enabling precise control over reactivity during chemical transformations.

The synthesis of cis-2-tert-Butoxycarbonylamino-2-methyl-cyclopentanecarboxylic Acid involves a multi-step process that combines principles from stereochemistry and organocatalysis. One notable approach reported in recent literature utilizes asymmetric induction techniques to achieve high enantiomeric excess (ee) during the formation of the chiral center. This method not only enhances the efficiency of the synthesis but also aligns with green chemistry principles by minimizing waste and reducing energy consumption.

In terms of applications, cis-2-tert-Butoxycarbonylamino-2-methyl-cyclopentanecarboxylic Acid has shown potential in the development of novel therapeutic agents. Its structure resembles certain bioactive molecules, suggesting that it could serve as a lead compound for drug discovery programs targeting specific enzymes or receptors. Additionally, its stability under various reaction conditions makes it suitable for use in combinatorial chemistry libraries, facilitating high-throughput screening for new drug candidates.

Recent advancements in computational chemistry have further expanded our understanding of this compound's properties. Molecular docking studies have revealed that its cyclopentane ring provides an ideal scaffold for interactions with protein targets, while the Boc group enhances solubility and bioavailability. These insights are particularly valuable for researchers aiming to optimize drug delivery systems and improve therapeutic outcomes.

Furthermore, the integration of machine learning algorithms into chemical research has enabled predictive modeling of cis-2-tert-Butoxycarbonylamino-2-methyl-cyclopentanecarboxylic Acid's behavior under different physiological conditions. By analyzing large datasets, scientists can now predict its pharmacokinetic profile with greater accuracy, streamlining the drug development process and reducing costs associated with trial-and-error methods.

In conclusion, cis-2-tert-Butoxycarbonylamino-2-methyl-cyclopentanecarboxylic Acid (CAS No. 1212127-10-0) stands out as a valuable compound in contemporary chemical research. Its unique structure, combined with advancements in synthetic and computational techniques, positions it as a key player in the development of innovative pharmaceuticals and materials. As research continues to uncover new applications and optimize its properties, this compound is poised to make significant contributions to various scientific disciplines.

• 136315-70-3(cis-2-(tert-butoxycarbonylamino)cyclopentanecarboxylic acid)
• 245115-25-7((1R,2R)-2-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid)
• 127057-07-2(2-tert-butoxycarbonylamino-cyclopentanecarboxylic acid)
• 192385-99-2(2-(tert-butoxycarbonylamino)cyclopentanecarboxylic acid)
• 130981-12-3(tert-butyl N-[(1S,2R)-2-(1-hydroxyethenyl)cyclopentyl]carbamate)
• 137170-89-9((1S,2R)-2-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid)
• 143679-80-5((1S,2S)-2-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid)
• 1212373-01-7(rac-(1R,2S,3R,4S)-3-{(tert-butoxy)carbonylamino}bicyclo2.2.1heptane-2-carboxylic acid)
• 76198-37-3(Boc-3-exo-aminobicyclo2.2.1-heptane-2-exo-carboxylic Acid)
• 136315-71-4(trans-2-(tert-butoxycarbonylamino)cyclopentanecarboxylic acid)